{"schema_version":"secwatch.filing_event.v1","accession":"0000721371-22-000101","form_type":"8-K","ticker":"CAH","cik":"0000721371","company_name":"CARDINAL HEALTH INC","filed_at":"2022-09-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.005225+00:00","generated_at":"2026-06-23T13:16:52.360042+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Cardinal Health announces Pharmaceutical Segment CEO change; Crawford out, Weitzman in","bullets":["Victor Crawford to step down as Pharmaceutical Segment CEO effective Sept 19, 2022; will stay until Nov 13 for transition.","Debbie Weitzman, former President of Pharmaceutical Distribution, named new CEO of Pharmaceutical Segment.","Role of President of Pharmaceutical Distribution eliminated; segment restructured with additional role eliminations.","Pharmaceutical and Specialty Distribution businesses will both report directly to Weitzman."],"urls":{"canonical":"https://secwatch.observer/filing/0000721371-22-000101","json":"https://secwatch.observer/filing/0000721371-22-000101.json","markdown":"https://secwatch.observer/filing/0000721371-22-000101.md","text":"https://secwatch.observer/filing/0000721371-22-000101.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/721371/000072137122000101/0000721371-22-000101-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/721371/000072137122000101/cah-20220907.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T13:16:52.360042+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b2cf910232","claim":"Victor L. Crawford departed as Chief Executive Officer, Pharmaceutical Segment at CARDINAL HEALTH INC.","evidence_excerpt":"On September 8, 2022, Cardinal Health, Inc. (the “Company”) announced that Victor L. Crawford will cease to serve as Chief Executive Officer, Pharmaceutical Segment effective September 19, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/721371/000072137122000101/0000721371-22-000101-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased to serve"},{"label":"Role","value":"Chief Executive Officer, Pharmaceutical Segment"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}